Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum – from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing – Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world.
Law firm focusing on conventional and engineered nanoscale chemical, pesticide, and other specialty chemical product approval and regulation, chemical product litigation, and associated business issues.
The oldest, largest and most respected dealer of used and refurbished semiconductor processing/manufacturing, microscopes, laboratory, electronic test and measurement, and general scientific equipment in the world.
Bing Energy, Inc. has an exclusive commercialization agreement to use Florida State University professor Dr. Jim P. Zheng's patented breakthrough nanotechnology to create a more commercially viable fuel cell. Building on the groundbreaking of Dr. Ben Wang, inventor of buckypaper, Zheng has pioneered a fuel cell that incorporates a thin membrane composed of carbon nanotubes, reducing the need for expensive platinum that, until now, have made fuel cells too expensive to be widely marketed.
As a manufacturer of nanoliter dispensing equipment,
BioDot has had extensive experience with the development
BioDot is the leading supplier of system tools for the research, development and commercialization of diagnostic tests. As a manufacturer of nanoliter dispensing equipment, BioDot has had extensive experience with the development of manufacturing processes for the protein array industry.
Developer of ultra-miniaturized nanoarray technologies. Molecular analysis systems are capable of providing nanometer scale, single molecule resolution. Applications in proteomics, diagnostics, and therapeutics.
A bionanotech designer and maker of nanostructured chips, devices and systems for fast, comprehensive, and low-cost analysis of native state genomic, epigenomic and proteomic information with sensitivity at the single cell / single molecule level.
The company develops skin care products with its proprietary nanotechnological platform based on the development of Bioactive Complex Modeling (NANO-COMPLEXES™) that has the ability to control nano- and pico- quantities of biologically active substances.
BioPAL provides products and methods to measure in vivo organ function and to track compounds-of-interest in in vivo systems. Products developed for neutron activation technology include nanocolloids for labeling, tracking and quantifying cells in in vivo models.